SAM
BIIB icon

Simplify Asset Management’s Biogen BIIB Stock Holding History

Simplify Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,470
Closed -$479K – 99
2024
Q3 		$479K Buy
2,470
+908
+58% +$190K 0.02% 90
2024
Q2 		$362K Buy
+1,562
New +$339K 0.02% 92
2023
Q3 		– Sell
-2,989
Closed -$851K – 124
2023
Q2 		$851K Buy
+2,989
New +$890K 0.11% 82
2023
Q1 		– Sell
-5,836
Closed -$1.62M – 121
2022
Q4 		$1.62M Buy
+5,836
New +$1.65M 0.25% 32

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Simplify Asset Management's BIIB Position: Q4 2024 in Review

Simplify Asset Management sold out of Biogen (BIIB) in Q4 2024, closing a stake of 2,470 shares — an estimated $479K sold.

Simplify Asset Management first reported a position in BIIB in Q4 2022 and held it in 4 quarters. The position peaked at $1.62M in Q4 2022. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Simplify Asset Management reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Simplify Asset Management sold 2,470 Biogen shares in Q4 2024, an estimated $479K.
  • Simplify Asset Management first reported a position in Biogen in Q4 2022 and held it in 4 quarters.
  • Simplify Asset Management's Biogen position peaked at $1.62M in Q4 2022.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Simplify Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.